Corbus Pharmaceuticals CRBP Stock
$10.17
4.414790%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$189.89M
LOW - HIGH [24H]
$9.74
-
$10.23
VOLUME [24H]
$352.52K
P/E Ratio
0
Earnings per share
-$6.11
ISIN
US21833P3010
Corbus Pharmaceuticals Price Chart
Corbus Pharmaceuticals CRBP Financial and Trading Overview
| Corbus Pharmaceuticals stock price | 10.17 USD |
| Previous Close | 9.74 USD |
| Open | 9.74 USD |
| Bid | 8.78 USD x 100 |
| Ask | 11.62 USD x 100 |
| Day's Range | 9.74 - 10.23 USD |
| 52 Week Range | 7.12 - 20.56 USD |
| Volume | 352.52K USD |
| Avg. Volume | 479.66K USD |
| Market Cap | 189.89M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -6.11 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 34.6 USD |
CRBP Valuation Measures
| Enterprise Value | 76.21M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.9889193 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.4279697 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.714 |
Trading Information
Corbus Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 17.30% |
| S&P500 52-Week Change | 21.71% |
| 52 Week High | 20.56 USD |
| 52 Week Low | 7.12 USD |
| 50-Day Moving Average | 8.68 USD |
| 200-Day Moving Average | 9.59 USD |
CRBP Share Statistics
| Avg. Volume (3 month) | 479.66K USD |
| Avg. Daily Volume (10-Days) | 242.05K USD |
| Shares Outstanding | 18.67M |
| Float | 14.43M |
| Short Ratio | 4.54 |
| % Held by Insiders | 1.03% |
| % Held by Institutions | 74.70% |
| Shares Short | 2.1M |
| Short % of Float | 13.02% |
| Short % of Shares Outstanding | 11.31% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -52.99% |
| Return on Equity (ttm) | -95.57% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -70095000 USD |
| EBITDA | -106680000 USD |
| Net Income Avi to Common (ttm) | -101903000 USD |
| Diluted EPS (ttm) | -6.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 117.94M USD |
| Total Cash Per Share (mrq) | 6.32 USD |
| Total Debt (mrq) | 4.26M USD |
| Total Debt/Equity (mrq) | 4.17 USD |
| Current Ratio (mrq) | 5.714 |
| Book Value Per Share (mrq) | 7.122 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Corbus Pharmaceuticals
| Country | United States |
| State | MA |
| City | Norwood |
| Address | 500 River Ridge Drive |
| ZIP | 02062 |
| Phone | 617 963 0100 |
| Website | https://www.corbuspharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 36 |
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Q&A For Corbus Pharmaceuticals Stock
What is a current CRBP stock price?
Corbus Pharmaceuticals CRBP stock price today per share is 10.17 USD.
How to purchase Corbus Pharmaceuticals stock?
You can buy CRBP shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Corbus Pharmaceuticals?
The stock symbol or ticker of Corbus Pharmaceuticals is CRBP.
Which industry does the Corbus Pharmaceuticals company belong to?
The Corbus Pharmaceuticals industry is Biotechnology.
How many shares does Corbus Pharmaceuticals have in circulation?
The max supply of Corbus Pharmaceuticals shares is 18.67M.
What is Corbus Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Corbus Pharmaceuticals PE Ratio is now.
What was Corbus Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Corbus Pharmaceuticals EPS is -6.11 USD over the trailing 12 months.
Which sector does the Corbus Pharmaceuticals company belong to?
The Corbus Pharmaceuticals sector is Healthcare.
Corbus Pharmaceuticals CRBP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26690.62 USD — |
+1.3
|
7.21B USD — | 26478.01 USD — | 26712.62 USD — | — - | 7.21B USD — |
|
US Tech Composite Total Return
XCMP
US
|
32930.06 USD — |
+1.3
|
— — | 32667.75 USD — | 32957.2 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1293.16 USD — |
+2.08
|
— — | 1273.79 USD — | 1294.2 USD — | — - | — — |
- {{ link.label }} {{link}}
